Nasdaq Moves Lower; Medtronic Posts Upbeat Earnings

Benzinga08-21

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 50 points on Tuesday.

The Dow traded down 0.10% to 40,854.31 while the NASDAQ fell 0.15% to 17,850.34. The S&P 500 also fell, dropping, 0.06% to 5,604.70.

Check This Out: Apple, Alphabet And 2 Other Stocks Insiders Are Selling

Leading and Lagging SectorsHealth care shares climbed by 0.5% on Tuesday.

In trading on Tuesday, energy shares fell by 1%.

Top Headline

Medtronic Plc (NYSE:MDT) reported better-than-expected results for its first quarter on Tuesday.

The company posted first-quarter 2025 sales of $7.92 billion, beating the consensus of $7.89 billion. The medical device maker reported adjusted EPS of $1.23, beating the consensus of $1.20. Revenue increased 2.8% year over year, as reported, and 5.3% organic.

Medtronic revised its fiscal year 2025 adjusted EPS guidance to $5.42 – $5.50, compared to prior guidance of $5.40 – $5.50 and consensus of $5.44. The company sees fiscal year 2025 organic revenue growth of 4.5% – 5% compared to prior guidance of 4% – 5%.

Equities Trading UP                       

  • InMed Pharmaceuticals Inc. (NASDAQ:INM) shares shot up 250% to $0.5075 after the company announced that INM-901 will be used in its development programs for Alzheimer’s Disease.
  • Shares of Bit Digital, Inc. (NASDAQ:BTBT) got a boost, surging 16% to $3.47 after the company reported better-than-expected second-quarter sales results. Also, the company announced a binding term sheet with Boosteroid.
  • Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) shares were also up, gaining 108% to $10.37. Titan Pharmaceuticals entered into merger and contribution and share exchange agreement regarding a business combination with KE Sdn. Bhd.

Equities Trading DOWN

  • Mynaric AG (NASDAQ:MYNA) shares dropped 54% to $1.93 after the company cut its FY24 revenue guidance.
  • Shares of ATRenew Inc. (NASDAQ:RERE) were down 12% to $2.5066 following second-quarter results.
  • Vipshop Holdings Limited (NYSE:VIPS) was down, falling 10% to $12.57 after the company reported second-quarter results and guided third-quarter revenues down approximately 5-10%.

CommoditiesIn commodity news, oil traded up 0.8% to $74.96 while gold traded up 1.1% at $2,568.90.

Silver traded up 2% to $29.875 on Tuesday, while copper rose 0.2% to $4.1875.

Euro zone

European shares were mostly lower today. The eurozone's STOXX 600 slipped 0.22%, Germany's DAX fell 0.09% and France's CAC 40 slipped 0.01%. Spain's IBEX 35 Index fell 0.32%, while London's FTSE 100 fell 0.85%.

The annual inflation rate in the Eurozone increased to 2.6% in July from 2.5% in the prior month, while current account surplus rose to €52.4 billion in June from €32.4 billion a year ago. Italy’s current account surplus widened to EUR 4,885 billion in June from EUR 1,248 billion in the year-ago period. Producer prices in Germany fell by 0.8% year-over-year in July.

Asia Pacific Markets

Asian markets closed mixed on Tuesday, with Japan's Nikkei 225 gaining 1.80%, Hong Kong's Hang Seng Index falling 0.33%, China's Shanghai Composite Index falling 0.93% and India's BSE Sensex rising 0.47%.

The annual inflation rate in Hong Kong increased to 2.5% in July from 1.5% in the prior month. The People’s Bank of China kept key lending rates unchanged at the recent fixing.

Economics

No major economic reports are scheduled for release today.

Now Read This:

  • Top 3 Tech Stocks Which Could Rescue Your Portfolio This Quarter
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment